Aptah Bio
PrivateLast Round
Seed
Dec 24, 2024
Total Funding Raised
$18M
Company Overview
Aptah Bio is a biotechnology company that develops first-in-class RNA therapeutics targeting U1 snRNP dysfunction to slow tumor evolution, reduce cancer heterogeneity, and overcome adaptive resistance in glioblastoma and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aptah Bio Comparables
Compare Aptah Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ceptur Therapeutics | 84% | |
| Skyhawk Therapeutics | 72% | |
| Inverna Therapeutics | 72% | |
Aptah Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 24, 2024 | ||||
| Series A | Aug 14, 2023 | ||||
| Accelerator | Aug 26, 2021 |
Key People
Founding team and executive leadership
Aptah Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taihill Venture | Seed |
| 5Y Capital | Seed |
| K2VC | Seed |
| UpHonest Capital | Seed |
| Financiadora de Estudos e Projetos | Series A |
| Mission BioCapital | Series A |
| Vesper | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 13, 2025
Monthly visitors increased 31% MoM.
- Feb 26, 2025
Monthly visitors increased 946% MoM, reaching 502.
Aptah Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aptah Bio's valuation, stock price, and market status.